Efficacy and Mechanisms of Virtual Reality Treatment of Phantom Leg Pain

虚拟现实治疗幻腿痛的疗效及机制

基本信息

  • 批准号:
    10297745
  • 负责人:
  • 金额:
    $ 62.95万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-09-10 至 2026-08-31
  • 项目状态:
    未结题

项目摘要

Project Summary Limb loss due to amputation is a common problem, occurring in nearly 2 million people in the US. Approximately 90% of individuals with limb amputation experience the persistent sensation of the missing extremity, known as a phantom limb, and up to 85% experience persistent and debilitating pain in the missing limb, termed phantom limb pain (hereafter PLP). We previously demonstrated that Virtual Reality (VR) with active leg movements and vision of a virtual limb significantly reduce phantom limb pain in subjects with below the knee amputations. The work proposed here has several objectives. In Specific Aim 1 we will randomize 40 subjects with PLP to treatment with our Active VR or a commercially available VR pain treatment (Cool!). In Specific Aim 2 we propose to develop a home intervention for PLP using the intervention (Active VR or Cool!) that in Specific Aim 1 proved to be most efficacious. In specific Aim 3 we will obtain multimodal ultra-high resolution (7T) MRI imaging in subjects with PLP before and after treatment, and normal subjects without amputation; we will also attempt to develop imaging biomarkers that predict efficacy of treatment. Imaging studies will address a number of controversies regarding the neural basis of PLP and explore human neuroplasticity more generally. Finally, in Specific Aim 4 we propose to determine factors that could be used in a clinical biomarker-based algorithm to predict response to home-based VR treatment. Using classification and regression tree (CART) analysis with the data from Aim 2, we will identify behavioral and neuroanatomic factors that predict treatment response. By the end of the grant period, we will have determined the relative efficacy of two VR treatments for PLP, assessed the feasibility and efficacy of a low-cost home-based treatment, determined the neuroanatomic changes associated with treatment response using advanced methods, and explored the behavioral and neuroimaging biomarkers predicting treatment response. These data will provide a critical step toward clinical implementation of a VR treatment protocol for PLP and will advance theoretical understanding of the mechanisms and functional neuroanatomy of PLP.
项目摘要 截肢导致的肢体丧失是一个常见的问题,在中国有近200万人 我们。约90%的截肢患者有持续性感觉 缺失的肢体,称为幻肢,高达85%的人经历持续和 丧失肢体的衰弱疼痛,称为幻肢疼痛(以下简称PLP)。我们之前 展示了具有主动腿部运动和虚拟肢体视觉的虚拟现实(VR) 显著减少膝关节以下截肢受试者的幻肢疼痛。这项工作 这里提出的建议有几个目标。在具体目标1中,我们将随机选择40名患有PLP的受试者 使用我们的主动VR或商用VR疼痛治疗(酷!)。以特定的目标 2我们建议使用干预(主动VR或Cool!)开发针对PLP的家庭干预。那 在特定的目标中,1被证明是最有效的。在具体目标3中,我们将获得多模式超高 PLP患者治疗前后及正常人的7T分辨率磁共振成像 在没有截肢的情况下,我们还将尝试开发预测截肢疗效的成像生物标志物 治疗。影像研究将解决一些关于PLP神经基础的争议 更广泛地探索人类的神经可塑性。最后,在具体目标4中,我们建议确定 可用于基于临床生物标记物的算法以预测家庭治疗反应的因素 VR治疗。使用分类和回归树(CART)分析来自目标2的数据,我们 将确定预测治疗反应的行为和神经解剖学因素。到年底的时候 在授权期内,我们将确定两种VR治疗PLP的相对疗效,评估 低成本家庭治疗的可行性和有效性,决定了神经解剖学的变化 使用先进的方法与治疗反应相关联,并探索了行为和 神经影像生物标记物预测治疗反应。这些数据将提供关键的一步 向临床实施PLP的VR治疗方案迈进,并将推动理论 了解PLP的发病机制和功能神经解剖学。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

LAUREL J BUXBAUM其他文献

LAUREL J BUXBAUM的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('LAUREL J BUXBAUM', 18)}}的其他基金

Mechanistic and neuroanatomic bases of disparity between arm capacity and use in stroke
中风患者手臂能力和使用差异的机制和神经解剖学基础
  • 批准号:
    10378853
  • 财政年份:
    2022
  • 资助金额:
    $ 62.95万
  • 项目类别:
Mechanistic and neuroanatomic bases of disparity between arm capacity and use in stroke
中风患者手臂能力和使用差异的机制和神经解剖学基础
  • 批准号:
    10670795
  • 财政年份:
    2022
  • 资助金额:
    $ 62.95万
  • 项目类别:
Efficacy and Mechanisms of Virtual Reality Treatment of Phantom Leg Pain
虚拟现实治疗幻腿痛的疗效及机制
  • 批准号:
    10693960
  • 财政年份:
    2021
  • 资助金额:
    $ 62.95万
  • 项目类别:
Understanding Action Selection in the Tool Use Network
了解工具使用网络中的操作选择
  • 批准号:
    9213205
  • 财政年份:
    2016
  • 资助金额:
    $ 62.95万
  • 项目类别:
Understanding the Conceptual-Motor Interface
了解概念运动接口
  • 批准号:
    8065855
  • 财政年份:
    2010
  • 资助金额:
    $ 62.95万
  • 项目类别:
Understanding the Conceptual-Motor Interface
了解概念运动接口
  • 批准号:
    8460838
  • 财政年份:
    2010
  • 资助金额:
    $ 62.95万
  • 项目类别:
Understanding the Conceptual-Motor Interface
了解概念运动接口
  • 批准号:
    7987337
  • 财政年份:
    2010
  • 资助金额:
    $ 62.95万
  • 项目类别:
Understanding the Conceptual-Motor Interface
了解概念运动接口
  • 批准号:
    8257553
  • 财政年份:
    2010
  • 资助金额:
    $ 62.95万
  • 项目类别:
Cognitive and Spatial Systems in Action
行动中的认知和空间系统
  • 批准号:
    6749440
  • 财政年份:
    1997
  • 资助金额:
    $ 62.95万
  • 项目类别:
SPATIAL AND NONSPATIAL FACTORS IN SELECTION FOR ACTION
选择行动时的空间和非空间因素
  • 批准号:
    2873222
  • 财政年份:
    1997
  • 资助金额:
    $ 62.95万
  • 项目类别:

相似海外基金

An innovative, AI-driven prehabilitation platform that increases adherence, enhances post-treatment outcomes by at least 50%, and provides cost savings of 95%.
%20创新、%20AI驱动%20康复%20平台%20%20增加%20依从性、%20增强%20治疗后%20结果%20by%20at%20至少%2050%、%20和%20提供%20成本%20节省%20of%2095%
  • 批准号:
    10057526
  • 财政年份:
    2023
  • 资助金额:
    $ 62.95万
  • 项目类别:
    Grant for R&D
Improving Repositioning Adherence in Home Care: Supporting Pressure Injury Care and Prevention
提高家庭护理中的重新定位依从性:支持压力损伤护理和预防
  • 批准号:
    490105
  • 财政年份:
    2023
  • 资助金额:
    $ 62.95万
  • 项目类别:
    Operating Grants
I-Corps: Medication Adherence System
I-Corps:药物依从性系统
  • 批准号:
    2325465
  • 财政年份:
    2023
  • 资助金额:
    $ 62.95万
  • 项目类别:
    Standard Grant
Unintrusive Pediatric Logging Orthotic Adherence Device: UPLOAD
非侵入式儿科记录矫形器粘附装置:上传
  • 批准号:
    10821172
  • 财政年份:
    2023
  • 资助金额:
    $ 62.95万
  • 项目类别:
Nuestro Sueno: Cultural Adaptation of a Couples Intervention to Improve PAP Adherence and Sleep Health Among Latino Couples with Implications for Alzheimer’s Disease Risk
Nuestro Sueno:夫妻干预措施的文化适应,以改善拉丁裔夫妇的 PAP 依从性和睡眠健康,对阿尔茨海默病风险产生影响
  • 批准号:
    10766947
  • 财政年份:
    2023
  • 资助金额:
    $ 62.95万
  • 项目类别:
CO-LEADER: Intervention to Improve Patient-Provider Communication and Medication Adherence among Patients with Systemic Lupus Erythematosus
共同领导者:改善系统性红斑狼疮患者的医患沟通和药物依从性的干预措施
  • 批准号:
    10772887
  • 财政年份:
    2023
  • 资助金额:
    $ 62.95万
  • 项目类别:
Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
  • 批准号:
    10594350
  • 财政年份:
    2023
  • 资助金额:
    $ 62.95万
  • 项目类别:
Antiretroviral therapy adherence and exploratory proteomics in virally suppressed people with HIV and stroke
病毒抑制的艾滋病毒和中风患者的抗逆转录病毒治疗依从性和探索性蛋白质组学
  • 批准号:
    10748465
  • 财政年份:
    2023
  • 资助金额:
    $ 62.95万
  • 项目类别:
Improving medication adherence and disease control for patients with multimorbidity: the role of price transparency tools
提高多病患者的药物依从性和疾病控制:价格透明度工具的作用
  • 批准号:
    10591441
  • 财政年份:
    2023
  • 资助金额:
    $ 62.95万
  • 项目类别:
Development and implementation of peer-facilitated decision-making and referral support to increase uptake and adherence to HIV pre-exposure prophylaxis in African Caribbean and Black communities in Ontario
制定和实施同行协助决策和转介支持,以提高非洲加勒比地区和安大略省黑人社区对艾滋病毒暴露前预防的接受和依从性
  • 批准号:
    491109
  • 财政年份:
    2023
  • 资助金额:
    $ 62.95万
  • 项目类别:
    Fellowship Programs
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了